This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Investigations

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Liver function tests:

  • raised serum alkaline phosphatase
  • raised serum aspartate aminotransferase in 90% of cases
  • raised serum bilirubin levels in many patients

Other features:

  • hypergammaglobulinaemia occurs in one third; IgM levels increased in 50% of cases
  • raised hepatic copper levels in nearly 90% of cases
  • autoantibodies are less frequent than in autoimmune chronic active hepatitis and primary biliary cirrhosis:
    • smooth muscle antibodies occur in 11% of cases
    • P-ANCA positive in more than 50% of cases
    • antinuclear antibodies in 6 to 35% of cases
    • antimitochondrial antibodies almost never occur

Liver biopsy may reveal:

  • a fibrous obliterating cholangitis
  • loss of interlobular and adjacent septal bile ducts

ERCP may demonstrate:

  • multiple annular strictures, separated by round or slightly dilated duct segments
  • the intrahepatic and extrahepatic bile ducts have a beaded appearance

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.